Updated Dec. 19, 2012 at 9:58 a.m.

Premium Lock C.H.-based drug firm Cempra launches Phase 3 trial

Published: 2012-12-19 09:49:00
Updated: 2012-12-19 09:58:02

Cempra  Cempra

Anitbiotics developer Cempra Pharmaceuticals (Nasdaq: CEMP), which in October completed a $25 million private placement of additional shares, has launched a new clinical trial....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders